PARENTERAL NUTRIENT ADMIXTURES AS DRUG VEHICLES - THEORY AND PRACTICE IN THE CRITICAL CARE SETTING

被引:15
作者
DRISCOLL, DF
BAPTISTA, RJ
MITRANO, FP
MASCIOLI, EA
BLACKBURN, GL
BISTRIAN, BR
机构
[1] NEW ENGLAND DEACONESS HOSP, NUTR SUPPORT SERV, BOSTON, MA 02215 USA
[2] MASSACHUSETTS COLL PHARM & ALLIED HLTH SCI, PHARM, BOSTON, MA 02115 USA
[3] NORTHEASTERN UNIV, COLL PHARM & ALLIED HLTH PROFESS, BOSTON, MA 02115 USA
[4] HARVARD UNIV, SCH MED, BOSTON, MA 02115 USA
[5] NEW ENGLAND DEACONESS HOSP, DEPT SURG, DIV NUTR, BOSTON, MA 02215 USA
[6] NEW ENGLAND DEACONESS HOSP, DEPT MED, DIV NUTR, BOSTON, MA 02215 USA
[7] DEACONESS HOME HLTH CARE CORP, OPERAT, BOSTON, MA USA
来源
DICP-THE ANNALS OF PHARMACOTHERAPY | 1991年 / 25卷 / 03期
关键词
D O I
10.1177/106002809102500312
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Parenteral nutrient (PN) admixtures are the most complex, extemporaneously compounded formulations routinely prepared for hospitalized and home-based patients. In addition, drugs are added with increasing frequency to PN admixtures, thus presenting even greater physicochemical challenges to this highly complex pharmaceutical product. The continuous infusion of selected drugs may provide pharmacokinetic and therapeutic advantages over conventional, intermittent, bolus methods of administration. Fluid conservation, cost savings, and a possible decrease in the risk of infection through reduced catheter manipulation and simplification of therapy provide additional incentives to consider the use of PN admixtures. The many advantages of PN admixtures make them an attractive approach to cost-effective care, with special clinical benefits achieved in the critical care setting. This article reviews our clinical experience using PN admixtures as drug vehicles for selected drugs and presents some theoretical as well as actual benefits associated with this practice.
引用
收藏
页码:276 / 283
页数:8
相关论文
共 69 条
[1]   IMPAIRED LEUKOCYTE FUNCTION IN PATIENTS WITH POORLY CONTROLLED DIABETES [J].
BAGDADE, JD ;
ROOT, RK ;
BULGER, RJ .
DIABETES, 1974, 23 (01) :9-15
[2]   BOLUS OR INTRAVENOUS-INFUSION OF RANITIDINE - EFFECTS ON GASTRIC PH AND ACID-SECRETION - A COMPARISON OF RELATIVE EFFICACY AND COST [J].
BALLESTEROS, MA ;
HOGAN, DL ;
KOSS, MA ;
ISENBERG, JI .
ANNALS OF INTERNAL MEDICINE, 1990, 112 (05) :334-339
[3]   STABILITY OF CIMETIDINE HYDROCHLORIDE IN A TOTAL NUTRIENT ADMIXTURE [J].
BAPTISTA, RJ ;
PALOMBO, JD ;
TAHAN, SR ;
VALICENTI, AJ ;
BISTRIAN, BR ;
ARKIN, CF ;
BLACKBURN, GL .
AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1985, 42 (10) :2208-2210
[4]  
BAPTISTA RJ, 1983, NUTR SUPP SERV, V3, P18
[5]   INSULIN PUMP THERAPY IMPROVES BLOOD-GLUCOSE CONTROL DURING HYPERALIMENTATION [J].
BERGMAN, M ;
RAVIKUMAR, S ;
AUERHAHN, C ;
DELSAVIO, N ;
SAVINO, J ;
FELIG, P .
ARCHIVES OF INTERNAL MEDICINE, 1984, 144 (10) :2013-2015
[6]   VERY LOW-DOSES OF WARFARIN CAN PREVENT THROMBOSIS IN CENTRAL VENOUS CATHETERS - A RANDOMIZED PROSPECTIVE TRIAL [J].
BERN, MM ;
LOKICH, JJ ;
WALLACH, SR ;
BOTHE, A ;
BENOTTI, PN ;
ARKIN, CF ;
GRECO, FA ;
HUBERMAN, M ;
MOORE, C .
ANNALS OF INTERNAL MEDICINE, 1990, 112 (06) :423-428
[7]   HYDROCHLORIC-ACID INFUSION FOR TREATMENT OF METABOLIC ALKALOSIS ASSOCIATED WITH RESPIRATORY-ACIDOSIS [J].
BRIMIOULLE, S ;
BERRE, J ;
DUFAYE, P ;
VINCENT, JL ;
DEGAUTE, JP ;
KAHN, RJ .
CRITICAL CARE MEDICINE, 1989, 17 (03) :232-236
[8]   HYDROCHLORIC-ACID INFUSION FOR TREATMENT OF METABOLIC ALKALOSIS - EFFECTS ON ACID-BASE-BALANCE AND OXYGENATION [J].
BRIMIOULLE, S ;
VINCENT, JL ;
DUFAYE, P ;
BERRE, J ;
DEGAUTE, JP ;
KAHN, RJ .
CRITICAL CARE MEDICINE, 1985, 13 (09) :738-742
[9]   ENTERAL NUTRITION IN THE CRITICALLY ILL PATIENT - ROLE OF HYPOALBUMINEMIA [J].
BRINSON, RR ;
PITTS, WM .
CRITICAL CARE MEDICINE, 1989, 17 (04) :367-370
[10]  
BRISMAR B, 1982, ARCH SURG-CHICAGO, V117, P1196